Vascular targeting as a strategy for cancer therapy

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J]. SCIENCE, 1998, 279 (5349) : 377 - 380

[2] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J]. CELL, 1994, 79 (07) : 1157 - 1164

[3] DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77

[4] Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature [J]. SCIENCE, 1997, 275 (5299) : 547 - 550

[5] BARRIERS TO DRUG-DELIVERY IN SOLID TUMORS [J]. SCIENTIFIC AMERICAN, 1994, 271 (01) : 58 - 65

[6] Organ targeting in vivo using phage display peptide libraries [J]. NATURE, 1996, 380 (6572) : 364 - 366

[7] SCHNITZER JE, 1997, VASCULAR ENDOTHELIUM, V3, P77

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J]. SCIENCE, 1998, 279 (5349) : 377 - 380

[2] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J]. CELL, 1994, 79 (07) : 1157 - 1164

[3] DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77

[4] Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature [J]. SCIENCE, 1997, 275 (5299) : 547 - 550

[5] BARRIERS TO DRUG-DELIVERY IN SOLID TUMORS [J]. SCIENTIFIC AMERICAN, 1994, 271 (01) : 58 - 65

[6] Organ targeting in vivo using phage display peptide libraries [J]. NATURE, 1996, 380 (6572) : 364 - 366

[7] SCHNITZER JE, 1997, VASCULAR ENDOTHELIUM, V3, P77